Aclaris Therapeutics to Participate in the 10th Annual SVB Leerink Global Healthcare Conference

Rhea-AI Summary

Aclaris Therapeutics, a clinical-stage biopharmaceutical company, announced its participation in the 10th Annual SVB Leerink Global Healthcare Conference on February 25, 2021. Management will engage in a virtual fireside chat at 8:00 a.m. ET and will be available for one-on-one meetings throughout the day. Investors can access a live audio webcast of the chat on the company's website, which will be archived for 30 days. Aclaris focuses on developing innovative drug candidates for immuno-inflammatory diseases, leveraging a strong R&D pipeline.

WAYNE, Pa., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that management will participate in a virtual fireside chat at the 10th Annual SVB Leerink Global Healthcare Conference on Thursday, February 25, 2021 at 8:00 a.m. ET. Management will be available February 25th throughout the day for virtual one-on-one meetings.

A live audio webcast of the fireside chat may be accessed through the “Events” page of the “Investors” section of Aclaris’ website, www.aclaristx.com. The webcast will be archived for at least 30 days on the Aclaris website.

About Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of drug candidates powered by a robust R&D engine exploring protein kinase regulation. For additional information, please visit www.aclaristx.com.

Aclaris Contact

investors@aclaristx.com

FAQ

When is Aclaris Therapeutics participating in the SVB Leerink Global Healthcare Conference?

Aclaris Therapeutics will participate on February 25, 2021.

What time is Aclaris's fireside chat at the conference?

The fireside chat is scheduled for 8:00 a.m. ET.

How can investors access the webcast of Aclaris's fireside chat?

Investors can access the live audio webcast on Aclaris's website under the 'Events' section.

Will the webcast be available after the event?

Yes, the webcast will be archived for at least 30 days.

What is the focus of Aclaris Therapeutics?

Aclaris Therapeutics focuses on developing novel drug candidates for immuno-inflammatory diseases.